Nucleic Acid Active Reagents/Kits for Panther and Fusion Instruments
Closed Pre-Solicitation Posted
- Solicitation number
- W81K0222Q0026
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Tripler Army Medical Center, Hawaii 96859, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice seeks nucleic acid active reagents and assay kits for Panther Instruments at Tripler Army Medical Center. The Regional Health Contracting Office - Pacific, in support of the Department of the Army Medical Command, intends to make a sole source award to Gen-Probe, Inc. for a firm fixed-price contract. The period of performance is from March 1, 2022 through September 30, 2026 and includes a base year and four one-year option periods. Responses to this notice are due by February 8, 2022 and shall be considered by the agency. All questions shall be directed to susan.m.fujita.civ@mail.mil.
There is no set-aside designated for this requirement. The NAICS code is 325413 and the procurement is for reagents and kits to support Panther Instruments. Gen-Probe, Inc. is identified as the potential incumbent. This notice fulfills FAR requirements but does not obligate the Government to make an award.
Notice text
2 versions
Update #2 · Latest ·
The Regional Health Contracting Office - Pacific, in support of MEDCOM, intends to make a sole source award to Gen-Probe, Inc. for a firm fixed-price contract for nucleic acid active reagents and assay kits for Panther Instruments at Tripler Army Medical Center. The NAICS code of this procurement is 325413. This requirement is for a period of performance from on or about 01 March 2022 through 30 September 2026 (base and four (4) one-year option periods).
The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.
This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency. All questions and responses concerning this notice shall be emailed to susan.m.fujita.civ@mail.mil.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
AMENDMENT 0001: The purpose of this amendment is to revise CLIN descriptions, increase the option period CLIN quantities, add CLINs x010 and x011 and revise Attachment 1. The due date for submission of quotations was extended to February 8, 2022 at 12:00 pm (HST).
Update #1 ·
The Regional Health Contracting Office - Pacific, in support of MEDCOM, intends to make a sole source award to Gen-Probe, Inc. for a firm fixed-price contract for nucleic acid active reagents and assay kits for Panther Instruments at Tripler Army Medical Center. The NAICS code of this procurement is 325413. This requirement is for a period of performance from on or about 01 March 2022 through 30 September 2026 (base and four (4) one-year option periods).
The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.
This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency. All questions and responses concerning this notice shall be emailed to susan.m.fujita.civ@mail.mil.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Nucleic Acid Active Reagents/Kits for Panther and Fusion Instruments | Pre-Solicitation | |
| Nucleic Acid Active Reagents/Kits for Panther Instruments | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity